Hypereosinophilic Syndrome Clinical Trials

Find Hypereosinophilic Syndrome Clinical Trials Near You

Study of Clinical Profiles of Patients Followed for Chronic Hypereosinophilia and/or Hypereosinophilic Syndrome by the Creation of a National Cohort

Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Observational
SUMMARY

Unexplained chronic hypereosinophilia (HE) and hypereosinophilic syndromes (HES) are heterogeneous regarding the organ involvements (heart, lungs, skin, .. or none), the evolutionary profiles, the response to treatments. Underlying mechanisms are largely unknown and may associate genetic predisposing factors (germinal ? somatic?), environmental factors (alimentation, tobacco use, hormones, infections, ..) The COHESion study aims to study all clinical and biological characteristics of HE/HES patients and their evolutionary profiles, with a focus on genetic factors and the mechanisms supporting transitory or persistant chronic HE/HES (in absence of any well identified extrinsic trigger like drugs, parasitosis, ..)

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Men or Women of any age :

• With the diagnosis criteria of hyperosinophlia OR hypereosinophilic syndrome OR specific organ eosinophilic disease according to the consensus conference of the International Cooperative Working Group on Eosinophil Disorders (ICOG-EO)

• With an AEC \> 1500/mm3 or organ damage related to the presence of eosinophils in the tissues or organs whatever the context (idiopathic, clonal or reactive, including drug-related, parasitic or allergic)

• HES diagnosis since 2005/01/01

• Patients socially insured

• Patient who agreed to participate to the study, its proceedings and duration.

Locations
Other Locations
France
Hôpital Roger Salengro, CHU
RECRUITING
Lille
Contact Information
Primary
Guillaume Lefevre, MD
Guillaume.lefevre@chru-lille.fr
03 20 44 55 72
Time Frame
Start Date: 2019-05-06
Estimated Completion Date: 2031-05
Participants
Target number of participants: 600
Treatments
Eosinophilia/Hypereosinophilic syndrome
patient with eosinophilia and/or hypereosinophilic syndrome
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov